Bavarian Nordic

For us, it is all about improving and saving lives. Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. Our values – our Bavarian Nordic DNA, as we call it – is what guides our actions. We act as persistent pioneers, we are embracing change, we value being boosted by the team, and we believe in protecting lives every day. If that is also a part of your DNA, we invite you to join us in Bavarian Nordic! We are a global team of more than 1,400 dedicated people with diverse backgrounds and viewpoints who are bound together by our commitment to protect lives every day. We believe in creating an inclusive and flexible workplace with a strong focus on personal and professional development, because we need each other to take things further. We operate in a world in constant flux and always explore new opportunities. So, if you are open-minded and have the willpower to succeed, we might just be a perfect fit. See your career opportunities at www.bavarian-nordic.com/careers

Orifarm

Orifarm is one of the largest European suppliers of parallel imported and generic pharmaceuticals. We provide high-quality pharmaceuticals at a low cost, and our ambition is to be the number one in making healthcare a better deal while creating value and savings for society and consumers. Internationally, we work together to fulfill our vision, always exploring new business areas to drive Orifarm to new heights.

Xellia Pharmaceuticals

Xellia Pharmaceuticals is a specialty pharmaceutical company and a global leader in providing anti-infective treatments and other critical care therapies for serious and often life-threatening conditions. Xellia has an extensive heritage in developing, manufacturing, and commercializing anti-infective products. Headquartered in Copenhagen, Denmark, and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1400 employees globally, including state-of-the-art manufacturing sites in China, Denmark, and Hungary. Our strong market position is built on more than 120 years of pharmaceutical industry experience.

eris oaknet healthcare pvt. ltd.

ERIS OAKNET is Productive in approach, Progressive in Spirit while being passionate to serve humanity through Price consciousness. We at Eris Oaknet practice values as being "Performance orientation"​, “Committed to learning”, "Integrity"​, “Innovation” and “Openness”. Team Eris Oaknet is Humane by being tough on eradication of ailments while being soft on affordability. ERIS OAKNET has a unique combination of a legacy business spanning over 4 decades in IPM along with an agile start up Lifesciences business thereby a powerful combination of a critical mass as well as the vibrancy and nimbleness of a new organisation. ERIS OAKNET Lifesciences was launched in April 2015 by R S Raghav and a distinguished team of professionals combining tremendous experience & expertise in varied domains, significant achievements & status amongst top 10 pharma companies in the Indian Pharmaceutical Market (IPM). The leadership team has a significant track record in scaling up business from Rs 50 crores to Rs 1500 crores and in providing significant growth opportunities to more than 2000 employees. In November 2016, team ERIS OAKNET along with a reputed PE firm with investments in varied businesses including healthcare scaled up the business by acquiring the Indian Operations of South African MNC Adcock Ingram Healthcare. The new entity thus created, Eris Oaknet Healthcare Pvt Ltd enjoys market presence of a legacy business of Cosme Farma (CFL) spanning more than four decades in such specialities as Dermatology, Gynaecology & Orthopaedics. ERIS OAKNET’s prime objective is to create a sustainable, scalable and speciality-focused Pharmaceutical organization in India. Our Exports business currently spanning across Asia and Africa regions complements our domestic operations. With more than 50 percent of our products manufactured in LL facilities with manufacturing partners who follow rigorous quality standards and are accredited by various global agencies, we have a stamp of quality.

TABROS PHARMA (Pvt) Ltd.

Tabros Pharma a prominent name in the pharmaceutical industry of Pakistan which has been ranked among Top-30 National Companies in the country, for its long standing dedication of 50 years. Tabros Pharma has initiated its operations back in 1971 at the business and trade hub of the country i.e. Karachi. From the day of its establishment; the organization has only move forward and never looked back; a gesture of untiring determination that has driven the organization to its position today. The state of the art manufacturing facility of Tabros Pharma is equipped with latest technological equipment and machineries governed by strict cGMP controls. The facility is highly synchronized to produce diverse range of dosages forms that mainly includes: • Tablets • Capsules • Liquids • Dry Powders • Parenterals (includes liquid injections, sterile dry powder, and topical preparation). The manufacturing facility has bifurcated functions of Cephalosporins, Quinolones and other Antibiotics for the effective implementation of quality control and maintenance practices.